| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | FBLN5 DLL4 AOAH NOTCH2NLA MATN4 PKD1L3 NOTCH2NLC ITPR1 ITPR2 ITPR3 FBN2 SLIT1 SLIT3 LRP2 DLK2 NID1 ADGRE1 PCDH10 FBN3 | 2.89e-09 | 749 | 97 | 19 | GO:0005509 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.67e-08 | 188 | 97 | 10 | GO:0005201 | |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 1.11e-07 | 3 | 97 | 3 | GO:0005220 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 4.43e-07 | 4 | 97 | 3 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 4.43e-07 | 4 | 97 | 3 | GO:0045703 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 4.43e-07 | 4 | 97 | 3 | GO:0047743 | |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 1.10e-06 | 5 | 97 | 3 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 1.10e-06 | 5 | 97 | 3 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 1.10e-06 | 5 | 97 | 3 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 1.10e-06 | 5 | 97 | 3 | GO:0047006 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 1.10e-06 | 5 | 97 | 3 | GO:0047787 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 1.10e-06 | 5 | 97 | 3 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 1.10e-06 | 5 | 97 | 3 | GO:0047086 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 2.20e-06 | 6 | 97 | 3 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 3.83e-06 | 7 | 97 | 3 | GO:0072582 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 6.11e-06 | 8 | 97 | 3 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 6.11e-06 | 8 | 97 | 3 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 6.11e-06 | 8 | 97 | 3 | GO:0035671 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 9.14e-06 | 9 | 97 | 3 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 9.14e-06 | 9 | 97 | 3 | GO:0070401 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 1.30e-05 | 10 | 97 | 3 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 1.30e-05 | 10 | 97 | 3 | GO:0032052 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 3.89e-05 | 14 | 97 | 3 | GO:0001758 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 3.89e-05 | 14 | 97 | 3 | GO:0004032 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 3.89e-05 | 14 | 97 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 8.60e-05 | 18 | 97 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 1.19e-04 | 20 | 97 | 3 | GO:0004303 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 1.39e-04 | 4 | 97 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 2.09e-04 | 24 | 97 | 3 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 2.66e-04 | 26 | 97 | 3 | GO:0004022 | |
| GeneOntologyMolecularFunction | NADPH binding | 2.66e-04 | 26 | 97 | 3 | GO:0070402 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 2.99e-04 | 27 | 97 | 3 | GO:0008106 | |
| GeneOntologyMolecularFunction | Notch binding | 2.99e-04 | 27 | 97 | 3 | GO:0005112 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 4.10e-04 | 30 | 97 | 3 | GO:0018455 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 4.53e-04 | 31 | 97 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 4.98e-04 | 32 | 97 | 3 | GO:0004033 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 5.45e-04 | 33 | 97 | 3 | GO:0033764 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 5.45e-04 | 33 | 97 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 5.96e-04 | 34 | 97 | 3 | GO:0016628 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 8.95e-04 | 39 | 97 | 3 | GO:0016229 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 9.64e-04 | 40 | 97 | 3 | GO:0016709 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 1.25e-03 | 11 | 97 | 2 | GO:0030283 | |
| GeneOntologyMolecularFunction | Roundabout binding | 1.49e-03 | 12 | 97 | 2 | GO:0048495 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 1.49e-03 | 12 | 97 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 1.64e-03 | 48 | 97 | 3 | GO:0016620 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 2.05e-03 | 14 | 97 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 2.56e-03 | 56 | 97 | 3 | GO:0016903 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 3.11e-03 | 60 | 97 | 3 | GO:0016655 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 3.42e-03 | 62 | 97 | 3 | GO:0016627 | |
| GeneOntologyMolecularFunction | NADP binding | 3.42e-03 | 62 | 97 | 3 | GO:0050661 | |
| GeneOntologyMolecularFunction | calcium channel activity | 3.62e-03 | 129 | 97 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | structural molecule activity | FBLN5 LAMB3 MATN4 TINAG FBN2 NID1 MUC4 MUC5AC MUC6 FBN3 OTOG | 3.95e-03 | 891 | 97 | 11 | GO:0005198 |
| GeneOntologyMolecularFunction | steroid binding | 4.04e-03 | 133 | 97 | 4 | GO:0005496 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 4.19e-03 | 20 | 97 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 4.85e-03 | 140 | 97 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | MRC1 OR13C3 OR2S2 PKD1L3 OR4L1 OR3A2 OR11A1 OR3A3 NID1 ROS1 GPRC5D OSMR TNFRSF1A ADGRE1 | 5.67e-03 | 1353 | 97 | 14 | GO:0004888 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 6.32e-03 | 151 | 97 | 4 | GO:0015085 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 4.15e-07 | 4 | 98 | 3 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 4.15e-07 | 4 | 98 | 3 | GO:0006709 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 4.15e-07 | 4 | 98 | 3 | GO:0071395 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 4.15e-07 | 4 | 98 | 3 | GO:0008208 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 1.03e-06 | 5 | 98 | 3 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 1.03e-06 | 5 | 98 | 3 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 1.03e-06 | 5 | 98 | 3 | GO:0045827 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 1.03e-06 | 5 | 98 | 3 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 1.03e-06 | 5 | 98 | 3 | GO:0120256 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 1.03e-06 | 5 | 98 | 3 | GO:1900053 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 2.06e-06 | 6 | 98 | 3 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 2.06e-06 | 6 | 98 | 3 | GO:0016095 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 3.59e-06 | 7 | 98 | 3 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 3.59e-06 | 7 | 98 | 3 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 3.59e-06 | 7 | 98 | 3 | GO:1900052 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 8.56e-06 | 9 | 98 | 3 | GO:0044597 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 1.22e-05 | 10 | 98 | 3 | GO:0044598 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 1.22e-05 | 10 | 98 | 3 | GO:0019747 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 1.22e-05 | 10 | 98 | 3 | GO:0046137 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 1.22e-05 | 10 | 98 | 3 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 1.22e-05 | 10 | 98 | 3 | GO:0030647 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 1.67e-05 | 11 | 98 | 3 | GO:2000224 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 1.67e-05 | 11 | 98 | 3 | GO:0016115 | |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 3.64e-05 | 14 | 98 | 3 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 3.64e-05 | 14 | 98 | 3 | GO:0008300 | |
| GeneOntologyBiologicalProcess | diterpenoid biosynthetic process | 4.54e-05 | 15 | 98 | 3 | GO:0016102 | |
| GeneOntologyBiologicalProcess | testosterone biosynthetic process | 5.57e-05 | 16 | 98 | 3 | GO:0061370 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 5.57e-05 | 16 | 98 | 3 | GO:0032351 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 6.61e-05 | 89 | 98 | 5 | GO:0001523 | |
| GeneOntologyBiologicalProcess | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration | 6.68e-05 | 3 | 98 | 2 | GO:0021834 | |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 8.06e-05 | 18 | 98 | 3 | GO:0030656 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 8.58e-05 | 94 | 98 | 5 | GO:0016101 | |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 9.33e-05 | 50 | 98 | 4 | GO:1905314 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 1.30e-04 | 21 | 98 | 3 | GO:0042447 | |
| GeneOntologyBiologicalProcess | terpenoid biosynthetic process | 1.30e-04 | 21 | 98 | 3 | GO:0016114 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid receptor signaling pathway | 1.30e-04 | 21 | 98 | 3 | GO:0048385 | |
| GeneOntologyBiologicalProcess | retinal metabolic process | 1.30e-04 | 21 | 98 | 3 | GO:0042574 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 1.30e-04 | 21 | 98 | 3 | GO:0042182 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 1.45e-04 | 105 | 98 | 5 | GO:0006721 | |
| GeneOntologyBiologicalProcess | prostaglandin metabolic process | 1.46e-04 | 56 | 98 | 4 | GO:0006693 | |
| GeneOntologyBiologicalProcess | parturition | 1.50e-04 | 22 | 98 | 3 | GO:0007567 | |
| GeneOntologyBiologicalProcess | glycoside metabolic process | 1.50e-04 | 22 | 98 | 3 | GO:0016137 | |
| GeneOntologyBiologicalProcess | progesterone metabolic process | 1.50e-04 | 22 | 98 | 3 | GO:0042448 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 1.50e-04 | 22 | 98 | 3 | GO:1902644 | |
| GeneOntologyBiologicalProcess | prostanoid metabolic process | 1.56e-04 | 57 | 98 | 4 | GO:0006692 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 1.72e-04 | 23 | 98 | 3 | GO:0071379 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 1.72e-04 | 23 | 98 | 3 | GO:0034310 | |
| GeneOntologyBiologicalProcess | regulation of Notch signaling pathway | 2.13e-04 | 114 | 98 | 5 | GO:0008593 | |
| GeneOntologyBiologicalProcess | embryonic olfactory bulb interneuron precursor migration | 2.21e-04 | 5 | 98 | 2 | GO:0021831 | |
| GeneOntologyBiologicalProcess | regulation of ketone biosynthetic process | 2.50e-04 | 26 | 98 | 3 | GO:0010566 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 3.13e-04 | 28 | 98 | 3 | GO:0048025 | |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 3.47e-04 | 29 | 98 | 3 | GO:0016093 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 3.47e-04 | 29 | 98 | 3 | GO:0050686 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell apoptotic process | 4.67e-04 | 32 | 98 | 3 | GO:2000353 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 5.12e-04 | 33 | 98 | 3 | GO:0033119 | |
| GeneOntologyBiologicalProcess | heart valve development | 5.22e-04 | 78 | 98 | 4 | GO:0003170 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 5.59e-04 | 34 | 98 | 3 | GO:0006706 | |
| GeneOntologyBiologicalProcess | olefinic compound biosynthetic process | 6.10e-04 | 35 | 98 | 3 | GO:0120255 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 6.24e-04 | 144 | 98 | 5 | GO:0006720 | |
| GeneOntologyBiologicalProcess | response to prostaglandin | 6.63e-04 | 36 | 98 | 3 | GO:0034694 | |
| GeneOntologyBiologicalProcess | isoprenoid biosynthetic process | 6.63e-04 | 36 | 98 | 3 | GO:0008299 | |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 7.78e-04 | 38 | 98 | 3 | GO:0048384 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 9.05e-04 | 40 | 98 | 3 | GO:0042573 | |
| GeneOntologyBiologicalProcess | negative regulation of chemokine-mediated signaling pathway | 9.81e-04 | 10 | 98 | 2 | GO:0070100 | |
| GeneOntologyBiologicalProcess | tangential migration from the subventricular zone to the olfactory bulb | 9.81e-04 | 10 | 98 | 2 | GO:0022028 | |
| GeneOntologyBiologicalProcess | response to calcium ion | 1.03e-03 | 161 | 98 | 5 | GO:0051592 | |
| GeneOntologyBiologicalProcess | cellular response to fatty acid | 1.04e-03 | 42 | 98 | 3 | GO:0071398 | |
| GeneOntologyBiologicalProcess | olfactory bulb interneuron development | 1.20e-03 | 11 | 98 | 2 | GO:0021891 | |
| GeneOntologyBiologicalProcess | vagina development | 1.20e-03 | 11 | 98 | 2 | GO:0060068 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone metabolic process | 1.28e-03 | 45 | 98 | 3 | GO:0008207 | |
| GeneOntologyBiologicalProcess | aortic valve development | 1.36e-03 | 46 | 98 | 3 | GO:0003176 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 1.45e-03 | 47 | 98 | 3 | GO:0046164 | |
| GeneOntologyBiologicalProcess | response to estrogen | 1.48e-03 | 103 | 98 | 4 | GO:0043627 | |
| GeneOntologyBiologicalProcess | negative regulation of Notch signaling pathway | 1.54e-03 | 48 | 98 | 3 | GO:0045746 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 1.64e-03 | 106 | 98 | 4 | GO:0034308 | |
| GeneOntologyBiologicalProcess | substrate-independent telencephalic tangential migration | 1.68e-03 | 13 | 98 | 2 | GO:0021826 | |
| GeneOntologyBiologicalProcess | substrate-independent telencephalic tangential interneuron migration | 1.68e-03 | 13 | 98 | 2 | GO:0021843 | |
| GeneOntologyBiologicalProcess | regulation of chemokine-mediated signaling pathway | 1.68e-03 | 13 | 98 | 2 | GO:0070099 | |
| GeneOntologyBiologicalProcess | endothelium development | 1.77e-03 | 182 | 98 | 5 | GO:0003158 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 1.83e-03 | 270 | 98 | 6 | GO:0007160 | |
| GeneOntologyBiologicalProcess | regulation of reactive oxygen species metabolic process | 2.04e-03 | 188 | 98 | 5 | GO:2000377 | |
| GeneOntologyBiologicalProcess | positive regulation of Notch signaling pathway | 2.05e-03 | 53 | 98 | 3 | GO:0045747 | |
| GeneOntologyBiologicalProcess | cellular response to cAMP | 2.05e-03 | 53 | 98 | 3 | GO:0071320 | |
| GeneOntologyCellularComponent | extracellular matrix | FBLN5 LAMB3 MATN4 ADAMTS12 TINAG FBN2 FCGBP NID1 USH2A MUC4 MUC5AC MUC6 FBN3 OTOG | 2.54e-06 | 656 | 99 | 14 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | FBLN5 LAMB3 MATN4 ADAMTS12 TINAG FBN2 FCGBP NID1 USH2A MUC4 MUC5AC MUC6 FBN3 OTOG | 2.63e-06 | 658 | 99 | 14 | GO:0030312 |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 8.48e-06 | 9 | 99 | 3 | GO:0031095 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 1.65e-05 | 11 | 99 | 3 | GO:0031094 | |
| MousePheno | parturition failure | 1.35e-05 | 10 | 69 | 3 | MP:0012010 | |
| MousePheno | hypermyelination | 1.85e-05 | 11 | 69 | 3 | MP:0010050 | |
| MousePheno | increased oligodendrocyte number | 3.18e-05 | 13 | 69 | 3 | MP:0010160 | |
| MousePheno | increased circulating progesterone level | 5.02e-05 | 15 | 69 | 3 | MP:0005186 | |
| MousePheno | long stride length | 5.02e-05 | 15 | 69 | 3 | MP:0010540 | |
| MousePheno | long gestation period | 5.02e-05 | 15 | 69 | 3 | MP:0002293 | |
| MousePheno | decreased vocalization | 7.59e-05 | 46 | 69 | 4 | MP:0020351 | |
| MousePheno | abnormal gestational length | 8.91e-05 | 18 | 69 | 3 | MP:0002292 | |
| MousePheno | dysmyelination | 1.24e-04 | 20 | 69 | 3 | MP:0013438 | |
| MousePheno | increased stereotypic behavior | 1.33e-04 | 53 | 69 | 4 | MP:0001409 | |
| MousePheno | decreased oligodendrocyte number | 2.45e-04 | 25 | 69 | 3 | MP:0009808 | |
| MousePheno | abnormal interventricular septum morphology | 2.70e-04 | 342 | 69 | 8 | MP:0000281 | |
| MousePheno | ventricular septal defect | 2.93e-04 | 261 | 69 | 7 | MP:0010402 | |
| MousePheno | abnormal estrous cycle | 3.11e-04 | 120 | 69 | 5 | MP:0001927 | |
| MousePheno | increased erythrocyte cell number | 3.48e-04 | 123 | 69 | 5 | MP:0003131 | |
| MousePheno | abnormal ovulation cycle | 3.89e-04 | 126 | 69 | 5 | MP:0009344 | |
| MousePheno | prolonged diestrus | 4.25e-04 | 30 | 69 | 3 | MP:0009011 | |
| MousePheno | increased grooming behavior | 4.82e-04 | 74 | 69 | 4 | MP:0001441 | |
| MousePheno | abnormal parturition | 5.65e-04 | 33 | 69 | 3 | MP:0002907 | |
| MousePheno | abnormal somatosensory cortex morphology | 5.65e-04 | 33 | 69 | 3 | MP:0000859 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | FBLN5 DLL4 NOTCH2NLA MATN4 NOTCH2NLC FBN2 SLIT1 SLIT3 LRP2 DLK2 NID1 ADGRE1 FBN3 | 7.05e-15 | 106 | 95 | 13 | IPR000152 |
| Domain | EGF-like_dom | FBLN5 DLL4 NOTCH2NLA MATN4 NOTCH2NLC TMEFF1 FBN2 FCGBP SLIT1 SLIT3 LRP2 DLK2 NID1 ADGRE1 MUC4 FBN3 OTOG | 7.81e-15 | 249 | 95 | 17 | IPR000742 |
| Domain | EGF_1 | FBLN5 DLL4 NOTCH2NLA LAMB3 MATN4 NOTCH2NLC TMEFF1 FBN2 SLIT1 SLIT3 LRP2 DLK2 NID1 ADGRE1 USH2A MUC4 FBN3 | 1.16e-14 | 255 | 95 | 17 | PS00022 |
| Domain | EGF_CA | FBLN5 DLL4 NOTCH2NLA MATN4 NOTCH2NLC FBN2 SLIT1 SLIT3 LRP2 DLK2 NID1 ADGRE1 FBN3 | 4.56e-14 | 122 | 95 | 13 | SM00179 |
| Domain | EGF_3 | FBLN5 DLL4 NOTCH2NLA MATN4 NOTCH2NLC TMEFF1 FBN2 SLIT1 SLIT3 LRP2 DLK2 NID1 ADGRE1 MUC4 FBN3 OTOG | 5.40e-14 | 235 | 95 | 16 | PS50026 |
| Domain | EGF | FBLN5 DLL4 NOTCH2NLA MATN4 NOTCH2NLC TMEFF1 FBN2 FCGBP SLIT1 SLIT3 LRP2 DLK2 NID1 ADGRE1 MUC4 FBN3 | 5.40e-14 | 235 | 95 | 16 | SM00181 |
| Domain | EGF-like_Ca-bd_dom | FBLN5 DLL4 NOTCH2NLA MATN4 NOTCH2NLC FBN2 SLIT1 SLIT3 LRP2 DLK2 NID1 ADGRE1 FBN3 | 5.65e-14 | 124 | 95 | 13 | IPR001881 |
| Domain | EGF-like_CS | FBLN5 DLL4 NOTCH2NLA LAMB3 MATN4 NOTCH2NLC TMEFF1 FBN2 SLIT1 SLIT3 LRP2 DLK2 NID1 ADGRE1 MUC4 FBN3 | 2.75e-13 | 261 | 95 | 16 | IPR013032 |
| Domain | EGF_2 | FBLN5 DLL4 NOTCH2NLA LAMB3 MATN4 NOTCH2NLC TMEFF1 FBN2 SLIT1 SLIT3 LRP2 DLK2 NID1 ADGRE1 MUC4 FBN3 | 3.48e-13 | 265 | 95 | 16 | PS01186 |
| Domain | EGF_Ca-bd_CS | FBLN5 NOTCH2NLA NOTCH2NLC FBN2 SLIT1 SLIT3 LRP2 DLK2 NID1 ADGRE1 FBN3 | 2.26e-12 | 97 | 95 | 11 | IPR018097 |
| Domain | EGF_CA | FBLN5 NOTCH2NLA NOTCH2NLC FBN2 SLIT1 SLIT3 LRP2 DLK2 NID1 ADGRE1 FBN3 | 2.84e-12 | 99 | 95 | 11 | PS01187 |
| Domain | ASX_HYDROXYL | FBLN5 DLL4 NOTCH2NLA MATN4 NOTCH2NLC FBN2 LRP2 DLK2 NID1 ADGRE1 FBN3 | 3.18e-12 | 100 | 95 | 11 | PS00010 |
| Domain | EGF | DLL4 NOTCH2NLA MATN4 NOTCH2NLC SLIT1 SLIT3 LRP2 DLK2 NID1 MUC4 FBN3 | 4.09e-11 | 126 | 95 | 11 | PF00008 |
| Domain | cEGF | 4.28e-11 | 26 | 95 | 7 | IPR026823 | |
| Domain | cEGF | 4.28e-11 | 26 | 95 | 7 | PF12662 | |
| Domain | EGF_CA | 5.16e-10 | 86 | 95 | 9 | PF07645 | |
| Domain | TIL_dom | 5.91e-09 | 14 | 95 | 5 | IPR002919 | |
| Domain | Growth_fac_rcpt_ | 6.80e-09 | 156 | 95 | 10 | IPR009030 | |
| Domain | VWD | 1.28e-08 | 16 | 95 | 5 | SM00216 | |
| Domain | VWF_type-D | 1.28e-08 | 16 | 95 | 5 | IPR001846 | |
| Domain | VWFD | 1.28e-08 | 16 | 95 | 5 | PS51233 | |
| Domain | VWD | 1.28e-08 | 16 | 95 | 5 | PF00094 | |
| Domain | CT | 7.53e-08 | 22 | 95 | 5 | SM00041 | |
| Domain | InsP3_rcpt-bd | 1.27e-07 | 3 | 95 | 3 | IPR000493 | |
| Domain | Cys_knot_C | 1.50e-07 | 25 | 95 | 5 | IPR006207 | |
| Domain | CTCK_2 | 1.50e-07 | 25 | 95 | 5 | PS01225 | |
| Domain | TIL | 3.01e-07 | 12 | 95 | 4 | PF01826 | |
| Domain | C8 | 3.01e-07 | 12 | 95 | 4 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 4.34e-07 | 13 | 95 | 4 | IPR014853 | |
| Domain | C8 | 4.34e-07 | 13 | 95 | 4 | SM00832 | |
| Domain | VWC_out | 2.30e-06 | 19 | 95 | 4 | SM00215 | |
| Domain | RIH_assoc | 2.52e-06 | 6 | 95 | 3 | PF08454 | |
| Domain | RIH_assoc-dom | 2.52e-06 | 6 | 95 | 3 | IPR013662 | |
| Domain | RIH_dom | 2.52e-06 | 6 | 95 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 2.52e-06 | 6 | 95 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 2.52e-06 | 6 | 95 | 3 | IPR015925 | |
| Domain | - | 2.52e-06 | 6 | 95 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 2.52e-06 | 6 | 95 | 3 | PF01365 | |
| Domain | Ins145_P3_rec | 2.52e-06 | 6 | 95 | 3 | PF08709 | |
| Domain | hEGF | 1.17e-05 | 28 | 95 | 4 | PF12661 | |
| Domain | MIR | 1.49e-05 | 10 | 95 | 3 | PS50919 | |
| Domain | MIR | 1.49e-05 | 10 | 95 | 3 | PF02815 | |
| Domain | MIR | 1.49e-05 | 10 | 95 | 3 | SM00472 | |
| Domain | ALDOKETO_REDUCTASE_1 | 1.49e-05 | 10 | 95 | 3 | PS00798 | |
| Domain | Aldo/ket_reductase_CS | 1.49e-05 | 10 | 95 | 3 | IPR018170 | |
| Domain | Aldo/keto_reductase | 1.49e-05 | 10 | 95 | 3 | IPR020471 | |
| Domain | MIR_motif | 1.49e-05 | 10 | 95 | 3 | IPR016093 | |
| Domain | ALDOKETO_REDUCTASE_2 | 1.49e-05 | 10 | 95 | 3 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 1.49e-05 | 10 | 95 | 3 | PS00063 | |
| Domain | LY | 5.55e-05 | 15 | 95 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 5.55e-05 | 15 | 95 | 3 | IPR000033 | |
| Domain | VWF_dom | 6.06e-05 | 42 | 95 | 4 | IPR001007 | |
| Domain | - | 6.80e-05 | 16 | 95 | 3 | 3.20.20.100 | |
| Domain | FBN | 7.65e-05 | 3 | 95 | 2 | IPR011398 | |
| Domain | NADP_OxRdtase_dom | 8.23e-05 | 17 | 95 | 3 | IPR023210 | |
| Domain | Aldo_ket_red | 8.23e-05 | 17 | 95 | 3 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 8.23e-05 | 17 | 95 | 3 | IPR001395 | |
| Domain | CTCK_1 | 9.84e-05 | 18 | 95 | 3 | PS01185 | |
| Domain | NIDO_dom | 2.53e-04 | 5 | 95 | 2 | IPR003886 | |
| Domain | NIDO | 2.53e-04 | 5 | 95 | 2 | SM00539 | |
| Domain | NIDO | 2.53e-04 | 5 | 95 | 2 | PF06119 | |
| Domain | Lipase_GDSL | 2.53e-04 | 5 | 95 | 2 | PF00657 | |
| Domain | NIDO | 2.53e-04 | 5 | 95 | 2 | PS51220 | |
| Domain | LIPASE_GDSL_SER | 2.53e-04 | 5 | 95 | 2 | PS01098 | |
| Domain | GDSL | 2.53e-04 | 5 | 95 | 2 | IPR001087 | |
| Domain | TB | 5.29e-04 | 7 | 95 | 2 | PF00683 | |
| Domain | - | 5.29e-04 | 7 | 95 | 2 | 3.40.50.1110 | |
| Domain | SGNH_hydro | 7.03e-04 | 8 | 95 | 2 | IPR013830 | |
| Domain | - | 7.03e-04 | 8 | 95 | 2 | 3.90.290.10 | |
| Domain | TB | 9.00e-04 | 9 | 95 | 2 | PS51364 | |
| Domain | TB_dom | 9.00e-04 | 9 | 95 | 2 | IPR017878 | |
| Domain | LAM_G_DOMAIN | 9.45e-04 | 38 | 95 | 3 | PS50025 | |
| Domain | - | 1.02e-03 | 39 | 95 | 3 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 1.10e-03 | 40 | 95 | 3 | IPR023415 | |
| Domain | Laminin_G_2 | 1.10e-03 | 40 | 95 | 3 | PF02210 | |
| Domain | Gprotein_B | 1.12e-03 | 10 | 95 | 2 | IPR001632 | |
| Domain | Fol_N | 1.37e-03 | 11 | 95 | 2 | IPR003645 | |
| Domain | FOLN | 1.37e-03 | 11 | 95 | 2 | SM00274 | |
| Domain | - | 1.40e-03 | 95 | 95 | 4 | 2.60.120.200 | |
| Domain | LamG | 1.45e-03 | 44 | 95 | 3 | SM00282 | |
| Domain | Ldl_recept_a | 1.55e-03 | 45 | 95 | 3 | PF00057 | |
| Domain | - | 1.65e-03 | 46 | 95 | 3 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.65e-03 | 46 | 95 | 3 | IPR011042 | |
| Domain | LDLRA_1 | 1.87e-03 | 48 | 95 | 3 | PS01209 | |
| Domain | CUB | 1.98e-03 | 49 | 95 | 3 | PF00431 | |
| Domain | LDLRA_2 | 1.98e-03 | 49 | 95 | 3 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 1.98e-03 | 49 | 95 | 3 | IPR002172 | |
| Domain | LDLa | 1.98e-03 | 49 | 95 | 3 | SM00192 | |
| Domain | CUB | 2.10e-03 | 50 | 95 | 3 | SM00042 | |
| Domain | Ldl_recept_b | 2.24e-03 | 14 | 95 | 2 | PF00058 | |
| Domain | LDLRB | 2.24e-03 | 14 | 95 | 2 | PS51120 | |
| Domain | - | 2.35e-03 | 52 | 95 | 3 | 2.60.120.290 | |
| Domain | CUB | 2.48e-03 | 53 | 95 | 3 | PS01180 | |
| Domain | Laminin_N | 2.93e-03 | 16 | 95 | 2 | IPR008211 | |
| Domain | LAMININ_NTER | 2.93e-03 | 16 | 95 | 2 | PS51117 | |
| Domain | Laminin_N | 2.93e-03 | 16 | 95 | 2 | PF00055 | |
| Domain | LamNT | 2.93e-03 | 16 | 95 | 2 | SM00136 | |
| Domain | CUB_dom | 3.06e-03 | 57 | 95 | 3 | IPR000859 | |
| Domain | Laminin_G | 3.21e-03 | 58 | 95 | 3 | IPR001791 | |
| Domain | EGF_extracell | 3.54e-03 | 60 | 95 | 3 | IPR013111 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 2.03e-07 | 190 | 65 | 9 | MM15687 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 6.64e-07 | 68 | 65 | 6 | M27303 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 9.30e-07 | 5 | 65 | 3 | M49000 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 1.85e-06 | 6 | 65 | 3 | M47960 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.89e-06 | 45 | 65 | 5 | MM15344 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 7.71e-06 | 9 | 65 | 3 | M39344 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 7.71e-06 | 9 | 65 | 3 | M47852 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 7.71e-06 | 9 | 65 | 3 | M47817 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.06e-05 | 109 | 65 | 6 | MM15164 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.10e-05 | 10 | 65 | 3 | M47661 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.18e-05 | 111 | 65 | 6 | M27416 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.50e-05 | 11 | 65 | 3 | M49033 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 1.50e-05 | 11 | 65 | 3 | M27466 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 1.50e-05 | 11 | 65 | 3 | M47812 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 2.59e-05 | 13 | 65 | 3 | M17842 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.59e-05 | 13 | 65 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 2.59e-05 | 13 | 65 | 3 | M47751 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 2.59e-05 | 13 | 65 | 3 | M47656 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 2.59e-05 | 13 | 65 | 3 | MM14747 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 2.59e-05 | 13 | 65 | 3 | MM14553 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | PLB1 OR13C3 OR2S2 AKR1C4 AKR1C1 OR4L1 ITPR3 OR3A2 OR11A1 LRP2 OR3A3 OTOG | 2.87e-05 | 636 | 65 | 12 | M41834 |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 3.28e-05 | 14 | 65 | 3 | M46449 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 3.28e-05 | 14 | 65 | 3 | M27074 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 3.28e-05 | 14 | 65 | 3 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 3.28e-05 | 14 | 65 | 3 | MM14748 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 4.09e-05 | 15 | 65 | 3 | MM14870 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 4.40e-05 | 140 | 65 | 6 | M27484 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 4.95e-05 | 143 | 65 | 6 | M27275 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 5.02e-05 | 16 | 65 | 3 | M27410 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 5.02e-05 | 16 | 65 | 3 | M26945 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 6.08e-05 | 17 | 65 | 3 | M27412 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 6.43e-05 | 92 | 65 | 5 | MM14881 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 6.88e-05 | 48 | 65 | 4 | M27642 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 8.60e-05 | 19 | 65 | 3 | M27423 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 8.60e-05 | 19 | 65 | 3 | M47760 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 8.60e-05 | 19 | 65 | 3 | M47733 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 1.01e-04 | 20 | 65 | 3 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 1.17e-04 | 21 | 65 | 3 | M47689 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.17e-04 | 21 | 65 | 3 | MM15706 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.35e-04 | 22 | 65 | 3 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.35e-04 | 22 | 65 | 3 | M47675 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.55e-04 | 23 | 65 | 3 | M556 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.55e-04 | 23 | 65 | 3 | M47676 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 1.55e-04 | 23 | 65 | 3 | M1926 | |
| Pathway | REACTOME_PREDNISONE_ADME | 1.55e-04 | 23 | 65 | 3 | MM16639 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 1.55e-04 | 23 | 65 | 3 | MM14741 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 2.00e-04 | 25 | 65 | 3 | MM14511 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 2.26e-04 | 26 | 65 | 3 | M27483 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 2.30e-04 | 189 | 65 | 6 | MM14772 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 2.53e-04 | 27 | 65 | 3 | M12123 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 2.53e-04 | 27 | 65 | 3 | MM15053 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 2.82e-04 | 28 | 65 | 3 | MM15188 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 2.82e-04 | 28 | 65 | 3 | M924 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 3.72e-04 | 74 | 65 | 4 | MM15962 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 4.22e-04 | 32 | 65 | 3 | MM14983 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 4.33e-04 | 7 | 65 | 2 | M47805 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 4.62e-04 | 33 | 65 | 3 | M5967 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 4.62e-04 | 33 | 65 | 3 | MM14737 | |
| Pathway | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | 5.99e-04 | 36 | 65 | 3 | M1315 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 5.99e-04 | 36 | 65 | 3 | M39831 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 6.50e-04 | 37 | 65 | 3 | M27134 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 6.58e-04 | 86 | 65 | 4 | M916 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 7.59e-04 | 39 | 65 | 3 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 7.59e-04 | 39 | 65 | 3 | MM15165 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 8.80e-04 | 41 | 65 | 3 | M512 | |
| Pathway | REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO | 9.20e-04 | 10 | 65 | 2 | M27348 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 9.45e-04 | 42 | 65 | 3 | M791 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.01e-03 | 250 | 65 | 6 | M27554 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 1.08e-03 | 44 | 65 | 3 | M499 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 1.08e-03 | 44 | 65 | 3 | M39845 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.08e-03 | 44 | 65 | 3 | M26969 | |
| Pathway | WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS | 1.12e-03 | 11 | 65 | 2 | M39749 | |
| Pathway | SIG_CHEMOTAXIS | 1.16e-03 | 45 | 65 | 3 | M5193 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 1.16e-03 | 45 | 65 | 3 | MM14751 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 1.16e-03 | 100 | 65 | 4 | M27158 | |
| Pathway | SIG_BCR_SIGNALING_PATHWAY | 1.23e-03 | 46 | 65 | 3 | M8626 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 1.48e-03 | 49 | 65 | 3 | MM15186 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 1.57e-03 | 50 | 65 | 3 | M47951 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 1.86e-03 | 53 | 65 | 3 | MM15716 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 1.94e-03 | 115 | 65 | 4 | M9387 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.96e-03 | 54 | 65 | 3 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.96e-03 | 54 | 65 | 3 | MM15202 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.96e-03 | 54 | 65 | 3 | M26911 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 2.07e-03 | 55 | 65 | 3 | M47952 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 2.07e-03 | 55 | 65 | 3 | M14933 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 2.17e-03 | 198 | 65 | 5 | M18311 | |
| Pathway | REACTOME_CGMP_EFFECTS | 2.41e-03 | 16 | 65 | 2 | M902 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.55e-03 | 300 | 65 | 6 | M610 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 2.65e-03 | 60 | 65 | 3 | MM15636 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 2.72e-03 | 17 | 65 | 2 | M39389 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 2.78e-03 | 61 | 65 | 3 | MM15071 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 2.78e-03 | 61 | 65 | 3 | MM14861 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 2.91e-03 | 62 | 65 | 3 | M546 | |
| Pathway | REACTOME_CA2_PATHWAY | 2.91e-03 | 62 | 65 | 3 | M27321 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 3.95e-03 | 140 | 65 | 4 | M587 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 4.11e-03 | 70 | 65 | 3 | M3115 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 4.11e-03 | 70 | 65 | 3 | M16794 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 4.11e-03 | 70 | 65 | 3 | M8232 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 4.11e-03 | 70 | 65 | 3 | MM14984 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 4.45e-03 | 72 | 65 | 3 | MM14631 | |
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 10874040 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 20395455 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 17437169 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 18547250 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 36350267 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 11413485 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 26009177 | ||
| Pubmed | Receptor-activated single channels in intact human platelets. | 2.31e-08 | 3 | 100 | 3 | 1693919 | |
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 23955339 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 31979185 | ||
| Pubmed | Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly. | 2.31e-08 | 3 | 100 | 3 | 24904548 | |
| Pubmed | Differential distribution of inositol trisphosphate receptor isoforms in mouse oocytes. | 2.31e-08 | 3 | 100 | 3 | 9858485 | |
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 9808793 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 18194433 | ||
| Pubmed | IP3 receptors regulate vascular smooth muscle contractility and hypertension. | 2.31e-08 | 3 | 100 | 3 | 27777977 | |
| Pubmed | Differential inositol 1,4,5-trisphosphate receptor signaling in a neuronal cell line. | 2.31e-08 | 3 | 100 | 3 | 17581770 | |
| Pubmed | Predominant role of type 1 IP3 receptor in aortic vascular muscle contraction. | 2.31e-08 | 3 | 100 | 3 | 18241669 | |
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 19068129 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 17327232 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 16014380 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 17890015 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. | 2.31e-08 | 3 | 100 | 3 | 23983250 | |
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 20427533 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 25215520 | ||
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 9.21e-08 | 4 | 100 | 3 | 10500239 | |
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 9.21e-08 | 4 | 100 | 3 | 14967952 | |
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 10393440 | ||
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 9.21e-08 | 4 | 100 | 3 | 15193432 | |
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 9.21e-08 | 4 | 100 | 3 | 31479646 | |
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 16191478 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 15577209 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 10702227 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 17034817 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 9.21e-08 | 4 | 100 | 3 | 29764944 | |
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 17888864 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 17442338 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 28329705 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 19237748 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 28259989 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 11163362 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 16511129 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 7789999 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 20124700 | ||
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 9.21e-08 | 4 | 100 | 3 | 16508162 | |
| Pubmed | Inositol 1, 4, 5-trisphosphate receptor interacts with the SNARE domain of syntaxin 1B. | 9.21e-08 | 4 | 100 | 3 | 21424589 | |
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 15222881 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 28615414 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 10828023 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 17629694 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 10526179 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 16018803 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 28419336 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 17272929 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 9.21e-08 | 4 | 100 | 3 | 18667791 | |
| Pubmed | IP3R-mediated Ca2+ signaling controls B cell proliferation through metabolic reprogramming. | 9.21e-08 | 4 | 100 | 3 | 35494252 | |
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 21521174 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 8274401 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 9.21e-08 | 4 | 100 | 3 | 34590152 | |
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 2.30e-07 | 5 | 100 | 3 | 21851338 | |
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 2.30e-07 | 5 | 100 | 3 | 16984997 | |
| Pubmed | MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. | 2.30e-07 | 5 | 100 | 3 | 16475027 | |
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 7737980 | ||
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 17872381 | ||
| Pubmed | InsP₃receptors and Orai channels in pancreatic acinar cells: co-localization and its consequences. | 2.30e-07 | 5 | 100 | 3 | 21568942 | |
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 2.30e-07 | 5 | 100 | 3 | 17064890 | |
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 10672042 | ||
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 38788959 | ||
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 18003893 | ||
| Pubmed | 2.48e-07 | 47 | 100 | 5 | 11208732 | ||
| Pubmed | 4.58e-07 | 6 | 100 | 3 | 23463619 | ||
| Pubmed | 4.58e-07 | 6 | 100 | 3 | 19273550 | ||
| Pubmed | 4.58e-07 | 6 | 100 | 3 | 15471942 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 4.58e-07 | 6 | 100 | 3 | 25966694 | |
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 4.58e-07 | 6 | 100 | 3 | 26748576 | |
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 4.58e-07 | 6 | 100 | 3 | 29107092 | |
| Pubmed | Sprouty2 regulates PI(4,5)P2/Ca2+ signaling and HIV-1 Gag release. | 4.58e-07 | 6 | 100 | 3 | 21762810 | |
| Pubmed | 4.58e-07 | 6 | 100 | 3 | 15860270 | ||
| Pubmed | 4.58e-07 | 6 | 100 | 3 | 20519450 | ||
| Pubmed | 4.58e-07 | 6 | 100 | 3 | 17122075 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 4.58e-07 | 6 | 100 | 3 | 17255200 | |
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 4.58e-07 | 6 | 100 | 3 | 16844763 | |
| Pubmed | 8.01e-07 | 7 | 100 | 3 | 22529366 | ||
| Pubmed | 8.01e-07 | 7 | 100 | 3 | 33127481 | ||
| Pubmed | 8.01e-07 | 7 | 100 | 3 | 11860456 | ||
| Pubmed | 8.01e-07 | 7 | 100 | 3 | 12562828 | ||
| Pubmed | Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes. | 8.01e-07 | 7 | 100 | 3 | 22495310 | |
| Pubmed | 8.01e-07 | 7 | 100 | 3 | 26160177 | ||
| Pubmed | Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. | 8.01e-07 | 7 | 100 | 3 | 34843575 | |
| Pubmed | 8.01e-07 | 7 | 100 | 3 | 16337335 | ||
| Pubmed | 1.07e-06 | 27 | 100 | 4 | 17077188 | ||
| Pubmed | 1.28e-06 | 8 | 100 | 3 | 33584538 | ||
| Pubmed | 1.28e-06 | 8 | 100 | 3 | 9224647 | ||
| Pubmed | 1.28e-06 | 8 | 100 | 3 | 20837989 | ||
| Pubmed | 1.91e-06 | 9 | 100 | 3 | 25737585 | ||
| Pubmed | 1.91e-06 | 9 | 100 | 3 | 15296947 | ||
| Pubmed | 1.91e-06 | 9 | 100 | 3 | 33348080 | ||
| Pubmed | 1.99e-06 | 71 | 100 | 5 | 33541421 | ||
| Pubmed | Lack of placental neurosteroid alters cortical development and female somatosensory function. | 2.73e-06 | 10 | 100 | 3 | 36313771 | |
| Interaction | TRPC4 interactions | 3.99e-06 | 23 | 96 | 4 | int:TRPC4 | |
| Interaction | AKR1C4 interactions | 5.77e-06 | 8 | 96 | 3 | int:AKR1C4 | |
| Interaction | TRPC1 interactions | 1.05e-05 | 29 | 96 | 4 | int:TRPC1 | |
| Interaction | ZNRF4 interactions | 1.43e-05 | 110 | 96 | 6 | int:ZNRF4 | |
| Interaction | OR4L1 interactions | 2.25e-05 | 2 | 96 | 2 | int:OR4L1 | |
| Interaction | AKR1C3 interactions | 2.83e-05 | 37 | 96 | 4 | int:AKR1C3 | |
| Interaction | IRAG1 interactions | 3.67e-05 | 14 | 96 | 3 | int:IRAG1 | |
| Interaction | POLR1E interactions | 4.46e-05 | 350 | 96 | 9 | int:POLR1E | |
| Interaction | SOX7 interactions | 4.51e-05 | 82 | 96 | 5 | int:SOX7 | |
| Interaction | CASZ1 interactions | 5.17e-05 | 43 | 96 | 4 | int:CASZ1 | |
| Interaction | TESPA1 interactions | 5.61e-05 | 16 | 96 | 3 | int:TESPA1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q31 | 1.32e-05 | 137 | 100 | 5 | chr9q31 | |
| Cytoband | 10p15-p14 | 7.01e-05 | 6 | 100 | 2 | 10p15-p14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 2.66e-04 | 404 | 100 | 6 | chr1q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p15 | 1.03e-03 | 90 | 100 | 3 | chr10p15 | |
| Cytoband | 5q35 | 1.15e-03 | 23 | 100 | 2 | 5q35 | |
| Cytoband | 1q21.3 | 2.18e-03 | 117 | 100 | 3 | 1q21.3 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 4.44e-08 | 3 | 65 | 3 | 297 | |
| GeneFamily | Aldo-keto reductases | 1.96e-05 | 15 | 65 | 3 | 399 | |
| GeneFamily | CD molecules|Mucins | 5.63e-05 | 21 | 65 | 3 | 648 | |
| GeneFamily | Olfactory receptors, family 3 | 1.89e-04 | 6 | 65 | 2 | 150 | |
| GeneFamily | WD repeat domain containing | 2.50e-03 | 262 | 65 | 5 | 362 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | FBLN5 LAMB3 MATN4 TINAG FBN2 SLIT1 SLIT3 NID1 USH2A FBN3 OTOG | 1.75e-10 | 196 | 97 | 11 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | FBLN5 LAMB3 MATN4 TINAG FBN2 SLIT1 SLIT3 NID1 USH2A FBN3 OTOG | 6.22e-09 | 275 | 97 | 11 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.95e-08 | 191 | 97 | 9 | MM17059 | |
| Coexpression | NABA_CORE_MATRISOME | 7.41e-07 | 270 | 97 | 9 | MM17057 | |
| Coexpression | NABA_MATRISOME | FBLN5 LAMB3 MATN4 GDF1 ADAMTS12 TINAG FBN2 SLIT1 SLIT3 NID1 USH2A MUC4 MUC5AC MUC6 FBN3 OTOG | 1.09e-06 | 1026 | 97 | 16 | M5889 |
| Coexpression | GSE3982_EOSINOPHIL_VS_MAST_CELL_UP | 9.44e-06 | 199 | 97 | 7 | M5397 | |
| Coexpression | TRAVAGLINI_LUNG_ARTERY_CELL | 9.46e-06 | 131 | 97 | 6 | M41662 | |
| Coexpression | NABA_MATRISOME | FBLN5 LAMB3 MATN4 GDF1 ADAMTS12 TINAG FBN2 SLIT1 SLIT3 NID1 MUC4 MUC5AC MUC6 OTOG | 2.03e-05 | 1008 | 97 | 14 | MM17056 |
| Coexpression | INGRAM_SHH_TARGETS_UP | 2.55e-05 | 156 | 97 | 6 | MM550 | |
| Coexpression | IRITANI_MAD1_TARGETS_UP | 3.22e-05 | 17 | 97 | 3 | MM826 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 5.35e-05 | 20 | 97 | 3 | MM17053 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 8.25e-05 | 23 | 97 | 3 | M48001 | |
| Coexpression | LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK | 9.40e-05 | 24 | 97 | 3 | MM766 | |
| Coexpression | GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_UP | 9.89e-05 | 199 | 97 | 6 | M7710 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_BCELL_UP | 1.02e-04 | 200 | 97 | 6 | M5515 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN | 1.07e-04 | 25 | 97 | 3 | MM480 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D | 1.11e-04 | 293 | 97 | 7 | MM895 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS | 1.86e-04 | 30 | 97 | 3 | MM853 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.66e-07 | 183 | 98 | 7 | 3427f3cbe6ea81709750e7dd3ff378f03ae65eab | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.72e-07 | 184 | 98 | 7 | f506d0ee48f39d6f59f19554217dfdf0987cc405 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.72e-07 | 184 | 98 | 7 | 8bcb1c4bc8ffef74338cdade926a94711de93c64 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-07 | 186 | 98 | 7 | 5302399825f213d105ac70b91366a4513b732838 | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.93e-07 | 187 | 98 | 7 | 66ebe1788d51b3e17bec6cdb219f709756b4e530 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-07 | 194 | 98 | 7 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-07 | 194 | 98 | 7 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-06 | 169 | 98 | 6 | 2a21f2cef959526bfe3c8f081f4f7e9dd4e01a37 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.49e-06 | 175 | 98 | 6 | af9c5104c86231cfdb93a0f7d7032379efaa009e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-06 | 175 | 98 | 6 | 77c16e615c0fb9c83f29d7e0a547be72635fac81 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.49e-06 | 175 | 98 | 6 | 4bfae78ac3a2cb9404382aae96d291504a9cfa14 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.93e-06 | 180 | 98 | 6 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.02e-06 | 181 | 98 | 6 | 4d7793026373cbcf04b15c77f95f1025d07d4c00 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.12e-06 | 182 | 98 | 6 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.12e-06 | 182 | 98 | 6 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-06 | 184 | 98 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-06 | 184 | 98 | 6 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-06 | 184 | 98 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-06 | 184 | 98 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.54e-06 | 186 | 98 | 6 | 9c7924875f70420720149287c500b4dfa8d24673 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery|Adult / Lineage, Cell type, age group and donor | 3.54e-06 | 186 | 98 | 6 | 2d1c4ea2e401db89971582ee54618a8b0c81b8ac | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.65e-06 | 187 | 98 | 6 | 12129e02638c20d9b7c1c6e512d48bfd966e1029 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.65e-06 | 187 | 98 | 6 | 83930ef55191eff9006113feaeabb3c2fa21fd05 | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-06 | 188 | 98 | 6 | 405efea75233ecf70f7d19b630230798d817b7f2 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.88e-06 | 189 | 98 | 6 | 9da012fdfa9a8d488cab710a463a1d70e89f990c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.88e-06 | 189 | 98 | 6 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.00e-06 | 190 | 98 | 6 | 8ff8c586237cf15f930416710bcff45205fe6f70 | |
| ToppCell | PND14-Epithelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.00e-06 | 190 | 98 | 6 | f1eeef8f201bf7b96c020c8ab53dd7e05b3060ea | |
| ToppCell | E17.5-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.00e-06 | 190 | 98 | 6 | 15f314517ed47b12d287a12a7d18cb383310e25a | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.00e-06 | 190 | 98 | 6 | 3b9abc25b17e7295356ded57ff2ca519fa9f2686 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.00e-06 | 190 | 98 | 6 | d87b9e9ca863270a9c7f61674271a6440c97d1f4 | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.12e-06 | 191 | 98 | 6 | f98fc372e579ce69409afbbe0f83c03c7ea62632 | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.12e-06 | 191 | 98 | 6 | 210589095a3f5d5117174caf6ec110b502f27030 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.12e-06 | 191 | 98 | 6 | 3307dbccadb09c62b0e1c0235ec89bb294d748c3 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.12e-06 | 191 | 98 | 6 | 5f8b3b2d38b37027901db9a1cccdbd1ff70f29de | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.12e-06 | 191 | 98 | 6 | 2f71f1fb6b5872d84860840b22e789a87ab14eec | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.12e-06 | 191 | 98 | 6 | 629007189034ee8451411428f1c6cc57daee2d91 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.12e-06 | 191 | 98 | 6 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.12e-06 | 191 | 98 | 6 | 4ab3056f9af2a6caed39f32288562f480811cd7b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.24e-06 | 192 | 98 | 6 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.24e-06 | 192 | 98 | 6 | 4a46f7980ec145be5b4bf8b98265e3e0f2ea4c63 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.24e-06 | 192 | 98 | 6 | 285a9d332a1e07b94f222d4b518dd56928b9e075 | |
| ToppCell | IPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 4.24e-06 | 192 | 98 | 6 | e911e286da26202853f9650ba3cdefe5a5c9b585 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 4.24e-06 | 192 | 98 | 6 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 4.24e-06 | 192 | 98 | 6 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.24e-06 | 192 | 98 | 6 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.37e-06 | 193 | 98 | 6 | c8c21eee8c6c086dc2faf416669cd4a002870fbe | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.37e-06 | 193 | 98 | 6 | 5b602b1702283184bd3943c2a6f2290b7c37e407 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-06 | 194 | 98 | 6 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-06 | 194 | 98 | 6 | cf0244a29934e515446ac917d3c30672b460fb04 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-06 | 194 | 98 | 6 | ba7f971fb9a19423602da60770f23d9fead4a451 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-06 | 194 | 98 | 6 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.64e-06 | 195 | 98 | 6 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.78e-06 | 196 | 98 | 6 | 1756254a61ea92601ed5e223ef4471f010c12216 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 4.78e-06 | 196 | 98 | 6 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.78e-06 | 196 | 98 | 6 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.78e-06 | 196 | 98 | 6 | b236be2fc0144c77a8840081bbb6ac6913e996f8 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.78e-06 | 196 | 98 | 6 | caa3c9555e1c656e88246ed31388a818f77610a1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.21e-06 | 199 | 98 | 6 | dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 5.21e-06 | 199 | 98 | 6 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 | |
| ToppCell | distal-Endothelial-Artery|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.21e-06 | 199 | 98 | 6 | b6e9aaac047d4b64b9d97f5e174e89a424d8b36d | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.21e-06 | 199 | 98 | 6 | fff88d2bba262583bb726900ae01e44954b72eb9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.21e-06 | 199 | 98 | 6 | c1760581c34b81d1d92c67500a1c8944e9cc6dad | |
| ToppCell | distal-Endothelial-Artery-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.21e-06 | 199 | 98 | 6 | 3788f3218356aaaa10684e48d63757037f8a3a3c | |
| ToppCell | moderate-Epithelial-Secretory-diff|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.36e-06 | 200 | 98 | 6 | 6f29ef9dcf126c5c19386f6aa9a20c38a2c8ccc8 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.36e-06 | 200 | 98 | 6 | ac6b8bc9998d303f788511b8f111e682ea9f3df8 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 5.36e-06 | 200 | 98 | 6 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.36e-06 | 200 | 98 | 6 | 7547d6339f9380d031cfd2cce21ac9a12491e085 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Secretory-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.36e-06 | 200 | 98 | 6 | 8f179b5768fd504af6dd6f6749a0bed7b689e77f | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.36e-06 | 200 | 98 | 6 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.36e-06 | 200 | 98 | 6 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.36e-06 | 200 | 98 | 6 | e90ca26643f8496bdd6672c327da9855490d1aa8 | |
| ToppCell | wk_20-22-Mesenchymal|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.36e-06 | 200 | 98 | 6 | 5c8557d2c414d8a8c518270f8c045b53cae45fb6 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 5.36e-06 | 200 | 98 | 6 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 5.36e-06 | 200 | 98 | 6 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.49e-06 | 122 | 98 | 5 | a7df7c9865364574833b79781281f156b9268ab1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.47e-06 | 128 | 98 | 5 | 076ba9de63b9a4b5a2f7e7924b9a86e8eafce91f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-05 | 145 | 98 | 5 | 051d964ff6bdc12ba3f0459d3e6ab16fa9507b0b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-05 | 146 | 98 | 5 | d33bd571c2adf5f89e6f02e77d094c19edd4729c | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.39e-05 | 155 | 98 | 5 | 9cad73d0b8ead289e1073d1a2e00bbeb1228308c | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 155 | 98 | 5 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.54e-05 | 157 | 98 | 5 | 275a4c6fef1fff8da2bdc48e3924ad05c5e5cfc8 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Club|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.62e-05 | 158 | 98 | 5 | 03281e87780e3bacd089903383c016d03c373bf7 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.95e-05 | 162 | 98 | 5 | 34b4cd3d2258f88dfbd6d32abd1db87aff8a6b6f | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.04e-05 | 163 | 98 | 5 | 56b8668dbf06faa6866ec71f29b92907b73f074d | |
| ToppCell | facs-Heart-LV-24m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 165 | 98 | 5 | 41707e66542ea27133043740ef9e58ab89b06607 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-05 | 169 | 98 | 5 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-05 | 170 | 98 | 5 | a121e10099faaeb60251eec162f38caf7c4238c2 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.4|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.03e-05 | 173 | 98 | 5 | 176b956e71d98e8275d698b39437fc326e5fe449 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-05 | 173 | 98 | 5 | 0bc2aacae60c6d3276b0949eb0748b4ac1f56e54 | |
| ToppCell | E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.03e-05 | 173 | 98 | 5 | b0ff9808e38cb64a734ced498cd0546728746cd5 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.15e-05 | 174 | 98 | 5 | 18ab52d8bbca0507fee220e0c4fc765fc47dda34 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.26e-05 | 175 | 98 | 5 | 2eca4c168dea2017ea0e383006e28abed22f32ec | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-05 | 175 | 98 | 5 | f7cd2ef79d91d64976fcdb5f1e7343b24ba27456 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.38e-05 | 176 | 98 | 5 | c2c4306476989bc2fb30dab00250ef7915842f13 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.38e-05 | 176 | 98 | 5 | 27e6b3ae41068d6cfdda3d46da7df2a27567140e | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.38e-05 | 176 | 98 | 5 | d6a5470af9592f34a741265f2ea9651c05c3add3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-05 | 177 | 98 | 5 | b872ee91e01265b101b81bd304cf6b95d5419e68 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.50e-05 | 177 | 98 | 5 | d68132e145bd413404fdbe215b5dbe520e756e50 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-05 | 178 | 98 | 5 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.19e-04 | 50 | 55 | 4 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_NOTCH_SIGNALING | |
| Drug | 5-dihydrodeoxycorticosterone | 7.73e-08 | 3 | 98 | 3 | ctd:C454687 | |
| Drug | tetrahydrodeoxycorticosterone | 3.08e-07 | 4 | 98 | 3 | ctd:C009413 | |
| Drug | Pregnanes | 3.08e-07 | 4 | 98 | 3 | ctd:D011278 | |
| Drug | tetralol | 3.08e-07 | 4 | 98 | 3 | ctd:C019106 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 3.08e-07 | 4 | 98 | 3 | ctd:C018156 | |
| Drug | cloxazolam | 3.08e-07 | 4 | 98 | 3 | ctd:C005522 | |
| Drug | Hydroxysteroids | 7.68e-07 | 5 | 98 | 3 | ctd:D006914 | |
| Drug | cresolphthalein | 7.68e-07 | 5 | 98 | 3 | ctd:C010092 | |
| Drug | Chrysenes | 1.48e-06 | 20 | 98 | 4 | ctd:D002911 | |
| Drug | Medazepam | 1.53e-06 | 6 | 98 | 3 | ctd:D008472 | |
| Drug | Ns 004 | 4.26e-06 | 8 | 98 | 3 | CID000162750 | |
| Drug | Nitrazepam | 4.26e-06 | 8 | 98 | 3 | ctd:D009567 | |
| Drug | 4-hydroxybenzoic acid | 6.37e-06 | 9 | 98 | 3 | ctd:C038193 | |
| Drug | 20-alpha-Dihydroprogesterone | 6.37e-06 | 9 | 98 | 3 | ctd:D004092 | |
| Drug | caged InsP3 | 7.06e-06 | 29 | 98 | 4 | CID000122248 | |
| Drug | octyl gallate | 9.08e-06 | 10 | 98 | 3 | ctd:C016627 | |
| Drug | AC1L2AC7 | 1.20e-05 | 69 | 98 | 5 | CID000068733 | |
| Drug | Dihydroxydihydrobenzopyrenes | 1.24e-05 | 11 | 98 | 3 | ctd:D004101 | |
| Drug | chlordecone alcohol | 1.24e-05 | 11 | 98 | 3 | CID000013946 | |
| Drug | NSC 60462 | 1.24e-05 | 11 | 98 | 3 | CID000097943 | |
| Drug | Phenolphthalein | 1.65e-05 | 12 | 98 | 3 | ctd:D020113 | |
| Drug | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | 1.83e-05 | 2 | 98 | 2 | DB07768 | |
| Drug | adenophostin A | 1.83e-05 | 2 | 98 | 2 | ctd:C085029 | |
| Drug | Isocaffeine | 1.83e-05 | 2 | 98 | 2 | CID000001326 | |
| Drug | adenophostin B | 1.83e-05 | 2 | 98 | 2 | CID000656722 | |
| Drug | benzene 1,2,4-trisphosphate | 1.83e-05 | 2 | 98 | 2 | CID000192376 | |
| Drug | DMBA-3,4-dihydrodiol | 2.14e-05 | 13 | 98 | 3 | CID000050096 | |
| Drug | 4-formyl-benzoate | 2.14e-05 | 13 | 98 | 3 | CID000012088 | |
| Drug | flunisolide | 2.14e-05 | 13 | 98 | 3 | ctd:C007734 | |
| Drug | 1-acenaphthenol | 2.72e-05 | 14 | 98 | 3 | CID000022750 | |
| Drug | 5-alpha-Dihydroprogesterone | 2.72e-05 | 14 | 98 | 3 | ctd:D043582 | |
| Drug | 6-.beta.-Naltrexol | 2.72e-05 | 14 | 98 | 3 | CID000631219 | |
| Drug | Meclofenamic Acid | 2.72e-05 | 14 | 98 | 3 | ctd:D008469 | |
| Drug | drospirenone | 3.39e-05 | 15 | 98 | 3 | ctd:C035144 | |
| Drug | 2gst | 3.52e-05 | 86 | 98 | 5 | CID000444461 | |
| Drug | 2-nitrobenzaldehyde | 4.16e-05 | 16 | 98 | 3 | CID000011101 | |
| Drug | 5-deoxy-5-fluoro-myo-inositol | 5.49e-05 | 3 | 98 | 2 | CID000195110 | |
| Drug | cyclopentanone | 5.49e-05 | 3 | 98 | 2 | ctd:C007201 | |
| Drug | 4-benzoylbenzoic acid | 5.49e-05 | 3 | 98 | 2 | ctd:C058818 | |
| Drug | cyclopentanol | 5.49e-05 | 3 | 98 | 2 | ctd:C016327 | |
| Drug | dichloro(4-cymene)ruthenium(II) | 5.49e-05 | 3 | 98 | 2 | ctd:C530610 | |
| Drug | Androstane-3,17-diol | 6.02e-05 | 18 | 98 | 3 | ctd:D015113 | |
| Drug | androstane-3,17-dione | 6.91e-05 | 51 | 98 | 4 | CID000000443 | |
| Drug | AC1L8ZBW | 7.13e-05 | 19 | 98 | 3 | CID000435356 | |
| Drug | oxcarbazepine | 7.13e-05 | 19 | 98 | 3 | ctd:C036006 | |
| Drug | benzo(a)pyrene-7,8-dione | 8.36e-05 | 20 | 98 | 3 | ctd:C076588 | |
| Drug | Hexestrol | 9.30e-05 | 55 | 98 | 4 | ctd:D006589 | |
| Drug | PE-3 | 9.72e-05 | 21 | 98 | 3 | CID000025056 | |
| Drug | Flunitrazepam | 9.72e-05 | 21 | 98 | 3 | ctd:D005445 | |
| Drug | 1,2-dihydroxynaphthalene | 1.07e-04 | 57 | 98 | 4 | CID000011318 | |
| Drug | gliquidone | 1.09e-04 | 4 | 98 | 2 | ctd:C010969 | |
| Drug | CHEBI:697555 | 1.09e-04 | 4 | 98 | 2 | CID009578246 | |
| Drug | DBD-H | 1.09e-04 | 4 | 98 | 2 | CID000131382 | |
| Drug | benzene dihydrodiol | 1.12e-04 | 22 | 98 | 3 | CID000000418 | |
| Drug | AC1L1KF5 | 1.30e-04 | 113 | 98 | 5 | CID000005470 | |
| Drug | nilvadipine | 1.31e-04 | 60 | 98 | 4 | CID000004494 | |
| Drug | Glycyrrhetinic Acid | 1.47e-04 | 24 | 98 | 3 | ctd:D006034 | |
| Drug | lercanidipine | 1.58e-04 | 63 | 98 | 4 | CID000065866 | |
| Drug | Pregnanolone | 1.66e-04 | 25 | 98 | 3 | ctd:D011280 | |
| Drug | 9,10-phenanthrenequinone | 1.66e-04 | 25 | 98 | 3 | ctd:C005399 | |
| Drug | NSC86000 | 1.82e-04 | 5 | 98 | 2 | CID000257630 | |
| Drug | chlordecone | 2.01e-04 | 67 | 98 | 4 | CID000000299 | |
| Drug | S-(+)-ibuprofen [51146-56-6]; Up 200; 19.4uM; MCF7; HT_HG-U133A | 2.11e-04 | 197 | 98 | 6 | 6471_UP | |
| Drug | AC1Q6O8T | 2.11e-04 | 197 | 98 | 6 | CID000002193 | |
| Drug | 3-nitropropionic acid; Up 200; 10uM; MCF7; HT_HG-U133A | 2.11e-04 | 197 | 98 | 6 | 6367_UP | |
| Drug | hexestrol | 2.60e-04 | 29 | 98 | 3 | CID000003606 | |
| Drug | AC1L93E5 | 2.72e-04 | 6 | 98 | 2 | CID000412383 | |
| Drug | acenaphthene-1-ol | 2.72e-04 | 6 | 98 | 2 | ctd:C023723 | |
| Drug | Estazolam | 2.72e-04 | 6 | 98 | 2 | ctd:D004949 | |
| Drug | 3-hydroxyhexobarbital | 2.72e-04 | 6 | 98 | 2 | CID000439898 | |
| Drug | Glipizide | 2.72e-04 | 6 | 98 | 2 | ctd:D005913 | |
| Drug | AC1Q7BER | 2.72e-04 | 6 | 98 | 2 | CID000005702 | |
| Drug | benzo(a)pyrene 7,8-dihydrodiol | 3.18e-04 | 31 | 98 | 3 | ctd:C017228 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 3.02e-07 | 5 | 93 | 3 | DOID:3030 (is_marker_for) | |
| Disease | bipolar II disorder | 1.68e-06 | 8 | 93 | 3 | EFO_0009964 | |
| Disease | congenital heart disease (implicated_via_orthology) | 2.67e-06 | 69 | 93 | 5 | DOID:1682 (implicated_via_orthology) | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 6.53e-06 | 12 | 93 | 3 | DOID:1441 (implicated_via_orthology) | |
| Disease | MALE PSEUDOHERMAPHRODITISM: DEFICIENCY OF TESTICULAR 17,20-DESMOLASE | 9.83e-06 | 2 | 93 | 2 | C1839840 | |
| Disease | Hypoxic Brain Damage | 9.83e-06 | 2 | 93 | 2 | C1140716 | |
| Disease | 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency | 9.83e-06 | 2 | 93 | 2 | cv:C1839840 | |
| Disease | 46,XY sex reversal 8 (is_implicated_in) | 9.83e-06 | 2 | 93 | 2 | DOID:0111773 (is_implicated_in) | |
| Disease | Majeed syndrome | 9.83e-06 | 2 | 93 | 2 | C1864997 | |
| Disease | 46,XY SEX REVERSAL 8 | 9.83e-06 | 2 | 93 | 2 | 614279 | |
| Disease | Anoxic Encephalopathy | 9.83e-06 | 2 | 93 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 9.83e-06 | 2 | 93 | 2 | C1527348 | |
| Disease | Anoxia of brain | 9.83e-06 | 2 | 93 | 2 | C0995195 | |
| Disease | response to docetaxel trihydrate | 9.83e-06 | 2 | 93 | 2 | GO_1902519 | |
| Disease | Neurodevelopmental Disorders | 1.16e-05 | 93 | 93 | 5 | C1535926 | |
| Disease | Prostatic Neoplasms | 2.49e-05 | 616 | 93 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.49e-05 | 616 | 93 | 10 | C0376358 | |
| Disease | Neoplasms, Hormone-Dependent | 2.94e-05 | 3 | 93 | 2 | C0027661 | |
| Disease | connective tissue disease (implicated_via_orthology) | 2.94e-05 | 3 | 93 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | pallidum volume change measurement, age at assessment | 6.63e-05 | 25 | 93 | 3 | EFO_0008007, EFO_0021494 | |
| Disease | Intellectual Disability | 8.62e-05 | 447 | 93 | 8 | C3714756 | |
| Disease | arecaidine measurement | 9.77e-05 | 5 | 93 | 2 | EFO_0801112 | |
| Disease | Hermaphroditism | 9.77e-05 | 5 | 93 | 2 | C0019269 | |
| Disease | Ambiguous Genitalia | 9.77e-05 | 5 | 93 | 2 | C0266362 | |
| Disease | Pseudohermaphroditism | 9.77e-05 | 5 | 93 | 2 | C0033804 | |
| Disease | Intersex Conditions | 9.77e-05 | 5 | 93 | 2 | C2930618 | |
| Disease | Sex Differentiation Disorders | 9.77e-05 | 5 | 93 | 2 | C2930619 | |
| Disease | Paroxysmal atrial fibrillation | 1.38e-04 | 156 | 93 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 1.38e-04 | 156 | 93 | 5 | C3468561 | |
| Disease | Non-Small Cell Lung Carcinoma | 1.38e-04 | 156 | 93 | 5 | C0007131 | |
| Disease | Persistent atrial fibrillation | 1.38e-04 | 156 | 93 | 5 | C2585653 | |
| Disease | Atrial Fibrillation | 1.56e-04 | 160 | 93 | 5 | C0004238 | |
| Disease | atrial fibrillation | 1.76e-04 | 371 | 93 | 7 | EFO_0000275 | |
| Disease | Hereditary Autoinflammatory Diseases | 2.04e-04 | 7 | 93 | 2 | C0751422 | |
| Disease | Disorders of Sex Development | 2.04e-04 | 7 | 93 | 2 | C0036875 | |
| Disease | biliary tract benign neoplasm (is_marker_for) | 2.04e-04 | 7 | 93 | 2 | DOID:0050625 (is_marker_for) | |
| Disease | mean arterial pressure, alcohol drinking | 2.66e-04 | 98 | 93 | 4 | EFO_0004329, EFO_0006340 | |
| Disease | total cholesterol measurement, response to escitalopram, response to citalopram | 2.72e-04 | 8 | 93 | 2 | EFO_0004574, EFO_0006329, EFO_0007871 | |
| Disease | free cholesterol change measurement, high density lipoprotein cholesterol measurement | 2.72e-04 | 8 | 93 | 2 | EFO_0004612, EFO_0020905 | |
| Disease | common bile duct neoplasm (is_marker_for) | 2.72e-04 | 8 | 93 | 2 | DOID:4608 (is_marker_for) | |
| Disease | diastolic blood pressure, self reported educational attainment | 2.72e-04 | 8 | 93 | 2 | EFO_0004784, EFO_0006336 | |
| Disease | multiple system atrophy | 2.75e-04 | 40 | 93 | 3 | EFO_1001050 | |
| Disease | leptin measurement, sex interaction measurement | 4.35e-04 | 10 | 93 | 2 | EFO_0005000, EFO_0008343 | |
| Disease | birth weight, pelvic organ prolapse | 5.03e-04 | 49 | 93 | 3 | EFO_0004344, EFO_0004710 | |
| Disease | diastolic blood pressure, alcohol drinking | 5.39e-04 | 118 | 93 | 4 | EFO_0004329, EFO_0006336 | |
| Disease | obesity (implicated_via_orthology) | 6.06e-04 | 215 | 93 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease (is_implicated_in) | 6.35e-04 | 12 | 93 | 2 | DOID:10595 (is_implicated_in) | |
| Disease | response to lithium ion | 7.44e-04 | 56 | 93 | 3 | GO_0010226 | |
| Disease | gastric ulcer (implicated_via_orthology) | 8.72e-04 | 14 | 93 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 9.95e-04 | 139 | 93 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.10e-03 | 64 | 93 | 3 | DOID:4947 (is_marker_for) | |
| Disease | Tetralogy of Fallot | 1.15e-03 | 16 | 93 | 2 | C0039685 | |
| Disease | response to methotrexate | 1.15e-03 | 16 | 93 | 2 | GO_0031427 | |
| Disease | otitis media (biomarker_via_orthology) | 1.30e-03 | 17 | 93 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | hematocrit | 1.32e-03 | 1011 | 93 | 10 | EFO_0004348 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.38e-03 | 152 | 93 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | bipolar disorder, sex interaction measurement | 1.45e-03 | 18 | 93 | 2 | EFO_0008343, MONDO_0004985 | |
| Disease | Colorectal Carcinoma | 1.70e-03 | 702 | 93 | 8 | C0009402 | |
| Disease | treatment resistant depression, response to antidepressant | 1.98e-03 | 21 | 93 | 2 | EFO_0009854, GO_0036276 | |
| Disease | susceptibility to scarlet fever measurement | 2.02e-03 | 79 | 93 | 3 | EFO_0008409 | |
| Disease | Leukemia, Myelocytic, Acute | 2.22e-03 | 173 | 93 | 4 | C0023467 | |
| Disease | spermatogenic failure (is_implicated_in) | 2.38e-03 | 23 | 93 | 2 | DOID:0111910 (is_implicated_in) | |
| Disease | Intrahepatic Cholangiocarcinoma | 2.59e-03 | 24 | 93 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 2.59e-03 | 24 | 93 | 2 | C3805278 | |
| Disease | age at menarche | 2.76e-03 | 594 | 93 | 7 | EFO_0004703 | |
| Disease | blood tin measurement | 2.81e-03 | 25 | 93 | 2 | EFO_0021530 | |
| Disease | Cholangiocarcinoma | 3.04e-03 | 26 | 93 | 2 | C0206698 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PVCNQVECHPYLNQS | 186 | P17516 | |
| NVHFVNDNTICYPCG | 31 | Q8NDM7 | |
| SPNFPVNYNNNHECI | 1111 | Q7Z408 | |
| AYYSLQCLCPNQHCE | 1221 | Q86V15 | |
| YCQQPICLSGCHEQN | 216 | Q9NR61 | |
| GNYTCVCPAEYLQVN | 1626 | Q75N90 | |
| IYDVHHQCQLQYGPN | 471 | P58397 | |
| HQCQLQYGPNATFCQ | 476 | P58397 | |
| QPISACCFNHNGNIF | 316 | P78406 | |
| NNTLVCNGLQNCVYP | 306 | Q8TDF5 | |
| NLPGSYQCQCLQGFT | 161 | Q7Z3S9 | |
| GPCICFENLTYNQAA | 851 | Q99650 | |
| NQNLESLTEYCQGPC | 1986 | Q14571 | |
| EYCQGPCHENQTCIV | 1946 | Q14573 | |
| NFQNEYPCNTQCIQS | 31 | P0DMB2 | |
| QLYSFLNCLQVSPCH | 446 | P28039 | |
| LCQNQSCPVNYCYNQ | 5116 | Q99102 | |
| LCSVGQCPANQVYQE | 296 | Q6W4X9 | |
| QLRFCGPNHIDQFYC | 166 | Q9GZK7 | |
| CRNNQGQLIAEPFYH | 396 | Q86U86 | |
| NEYCVVCDEPHVFQN | 506 | Q8N3A8 | |
| QQQDNLCPFCGKCYH | 461 | Q8NEZ4 | |
| GSYFCHCQVGFVLQQ | 276 | O95460 | |
| SIQGHNDYICPATNQ | 176 | Q92731 | |
| YCQGPCHENQNCIAT | 2051 | Q14643 | |
| FSEYSNVQQCPHCGN | 511 | Q9UBI9 | |
| NVQQCPHCGNLDYHF | 516 | Q9UBI9 | |
| FLANYCQGQCALPVA | 291 | P27539 | |
| CVLNYRFQLQHPGFQ | 96 | Q4VX62 | |
| NFCGPNEVNHFYCDL | 176 | P47893 | |
| NFCGPNEVNHFYCDL | 176 | P47888 | |
| LPFCGHNVINNIFCD | 166 | Q8NH43 | |
| QRPINYCETGLHNCD | 756 | P14543 | |
| ALSQCPQGHNYCSVN | 1201 | P14543 | |
| DHQYCIQSLQCGSGN | 781 | Q96LU7 | |
| HQITCSNGQCIPSEY | 111 | P98164 | |
| CNTHCPVGFEYQEQS | 5426 | P98088 | |
| QLPFCGDNVINHFTC | 166 | Q9NQN1 | |
| NQNYCYQVCLTPESA | 816 | Q9P2E7 | |
| CNPGNQAFHYVCQRL | 191 | Q9Y4D8 | |
| CYVCDQQTNGVFNPA | 296 | O15541 | |
| NLPGSYQCQCLQGFT | 161 | P0DPK4 | |
| YHQGVVIVTCPGCQN | 91 | Q5SXM8 | |
| QGNACPVTAYQHSFQ | 276 | Q9NZD1 | |
| PAQYFQGCLLDACQV | 3486 | Q9Y6R7 | |
| TIQPGCQNVCYDQAF | 56 | P36382 | |
| CQNVCYDQAFPISHI | 61 | P36382 | |
| SRGCFHACISYQNQP | 251 | O15033 | |
| HACISYQNQPINNGE | 256 | O15033 | |
| PTDQGCYPLNNHLFC | 346 | Q8WUP2 | |
| IGSQPFTCYFNQHQR | 141 | Q86W47 | |
| TYANPQGCHRCDCNI | 421 | Q13751 | |
| VCQPQGRFSTQCQYQ | 171 | Q5T749 | |
| VPLNFNQQEYICGSH | 116 | Q9NPI7 | |
| APHYAPACQDQECQV | 346 | Q6UY11 | |
| FLCQHECVNQPGTYF | 256 | Q9UBX5 | |
| SFQNICVFGTCNNLP | 1496 | P35556 | |
| NCLCYPGFELTHNND | 1956 | P35556 | |
| DCQPHGCQAQVTFNF | 56 | P60507 | |
| LPFCGNNIINHFACE | 196 | Q8NGS6 | |
| RNQCSCHFQGVDYPP | 841 | Q6ZRI0 | |
| DINCGYPNAFICQRH | 911 | P22897 | |
| QVYAFNCKPCQCNSH | 566 | O75445 | |
| RIQEAQPNHQCCSGY | 3226 | O75445 | |
| QPNHQCCSGYYARIL | 3231 | O75445 | |
| QAQVYEVVPCHSDCN | 1081 | Q9UPZ6 | |
| NSQCGQPFHQICLYE | 326 | Q9NW38 | |
| LCHFNNGEICFPFQQ | 966 | Q5QGS0 | |
| ICQHCYRQFSTPFQL | 531 | Q7Z3K3 | |
| LGFQYQPNCTHFHLN | 561 | Q7Z443 | |
| HPFNLQYGAQQTACN | 1306 | Q5VXU9 | |
| NNSLVCNGVQNCAYP | 311 | Q8NC67 | |
| QCYLCPSAQQNGLAA | 176 | Q6P1J6 | |
| CINPNAGFVHQLQEY | 156 | Q8WUJ0 | |
| ACPEHATCNNTVGNY | 181 | Q14246 | |
| PVCNQVECHPYFNQR | 186 | Q04828 | |
| PVCNQVECHPYFNQR | 186 | P52895 | |
| QCHISDQGEPYCLCQ | 1421 | O75094 | |
| QYCSGGNPFEIQANH | 516 | Q96JG6 | |
| HTGERPYQCNQCKQS | 226 | O75820 | |
| QSDEQYACHLGCQNQ | 106 | Q9BXS4 | |
| YACHLGCQNQLPFAE | 111 | Q9BXS4 | |
| NPNHCNCIIDQIFTG | 191 | A6NNY8 | |
| LKGHSNYVFCCNFNP | 121 | Q86VZ2 | |
| QNPYSHGNIVKNCCE | 271 | Q9Y397 | |
| SPVRVCQNCYYNLQH | 3501 | Q8IZQ1 | |
| EHGFYVTDCPQQQAQ | 201 | H3BPM6 | |
| LQCQGFYQLCGVHQE | 306 | Q5K4L6 | |
| TDNNIPHGQCVICLY | 126 | Q96BH1 | |
| TVNGKYCCPQLFINH | 521 | Q5VUG0 | |
| CSQGPAYVCNITNLQ | 1706 | P08922 | |
| HNYCINYGNCELPVE | 616 | Q6AHZ1 | |
| GSYNPRDGIHCLQCN | 326 | Q9BS86 | |
| TCHQCAQQLQGQQFY | 411 | Q15942 | |
| NNPTLHFGNNFYQCV | 451 | Q9UL58 | |
| QCTVCQSEYNNLHGL | 1471 | Q96JM2 | |
| HQPQTCTLSQCFQLY | 591 | Q70CQ4 | |
| FQCHTNYIPVCGSNG | 101 | Q8IYR6 | |
| QVHEAVPCYSECNQY | 1046 | Q9C0I4 | |
| VQPCLLNENCFQFQY | 1171 | Q9C0I4 | |
| NGFYRNNICSQPDLH | 216 | Q01831 | |
| CYPLFKDQNATNNGC | 306 | Q9UJW2 | |
| NQGTCHNDPLEVYRC | 936 | O75093 | |
| YQCNGNLSVDNCSPY | 1631 | Q6N021 | |
| QGKYIHPQNNSICCT | 46 | P19438 | |
| KGHSNYVFCCNFNPQ | 126 | P61964 | |
| QQIHTGEKPYQCQEC | 636 | A8MQ14 | |
| KPYLCQQCGAAFAHN | 436 | O95365 | |
| DGPQNRYALICQQCF | 266 | Q9C0E8 | |
| VQQQDGSYQCSPFHV | 36 | Q92539 |